AbbVie Inc. (ETR:4AB)
175.60
+0.60 (0.34%)
Aug 15, 2025, 5:35 PM CET
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
€903,023
Profits / Employee
€57,639
Market Cap
311.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
Dec 31, 2023 | 50,000 | 0 | - |
Dec 31, 2022 | 50,000 | 0 | - |
Dec 31, 2021 | 50,000 | 3,000 | 6.38% |
Dec 31, 2020 | 47,000 | 17,000 | 56.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
AbbVie News
- 3 days ago - My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys - Seeking Alpha
- 4 days ago - AbbVie: H1 2025 Earnings Strengthen Case For Targeting Gilgamesh Acquisition - Seeking Alpha
- 4 days ago - AbbVie to invest $195M to build plant in Illinois - Seeking Alpha
- 4 days ago - AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S. - PRNewsWire
- 7 days ago - Insider Transactions Highlight AbbVie (ABBV) Executive's Stock Sale - GuruFocus
- 7 days ago - Insider trades: AbbVie, Coca Cola , Roblox among notable names this week - Seeking Alpha
- 8 days ago - AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules - Benzinga
- 8 days ago - Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79% - Benzinga